Onyx Pharmaceuticals to Present at the 29th Annual Canaccord Adams Global Growth Conference
EMERYVILLE, Calif., Aug. 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the 29th Annual Canaccord Adams Global Growth Conference on Thursday, August 13, at 10:30 a.m. Eastern Time. Interested parties may access a live webcast of the presentation on our website at:
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available one hour following the conclusion of the presentation through September 13, 2009.
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit the company's website at www.onyxpharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.
You May Also Like